Literature DB >> 24305634

Mechanisms of exercise intolerance in heart failure with preserved ejection fraction.

Barry A Borlaug1.   

Abstract

Approximately half of patients with heart failure (HF) have a preserved ejection fraction (HFpEF), and with the changing age and comorbidity characteristics in the adult population, this number is growing rapidly. The defining symptom of HFpEF is exercise intolerance, but the specific mechanisms causing this common symptom remain debated and inadequately understood. Although diastolic dysfunction was previously considered to be the sole contributor to exercise limitation, recent studies have identified the importance of ventricular systolic, chronotropic, vascular, endothelial and peripheral factors that all contribute in a complex and highly integrated fashion to produce the signs and symptoms of HF. This review will explore the mechanisms underlying objective and subjective exercise intolerance in patients with HFpEF.

Entities:  

Mesh:

Year:  2013        PMID: 24305634     DOI: 10.1253/circj.cj-13-1103

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  31 in total

1.  Myocardial Energetics in Heart Failure With Preserved Ejection Fraction.

Authors:  Omar F AbouEzzeddine; Bradley J Kemp; Barry A Borlaug; Brian P Mullan; Atta Behfar; Sorin V Pislaru; Marat Fudim; Margaret M Redfield; Panithaya Chareonthaitawee
Journal:  Circ Heart Fail       Date:  2019-10-15       Impact factor: 8.790

Review 2.  The pathophysiology of heart failure with preserved ejection fraction.

Authors:  Barry A Borlaug
Journal:  Nat Rev Cardiol       Date:  2014-06-24       Impact factor: 32.419

3.  Heart rate response and functional capacity in patients with chronic heart failure with preserved ejection fraction.

Authors:  Eloy Domínguez; Patricia Palau; Eduardo Núñez; José María Ramón; Laura López; Joana Melero; Alejandro Bellver; Enrique Santas; Francisco J Chorro; Julio Núñez
Journal:  ESC Heart Fail       Date:  2018-03-24

4.  Effect of inorganic nitrate on exercise capacity in heart failure with preserved ejection fraction.

Authors:  Payman Zamani; Deepa Rawat; Prithvi Shiva-Kumar; Salvatore Geraci; Rushik Bhuva; Prasad Konda; Paschalis-Thomas Doulias; Harry Ischiropoulos; Raymond R Townsend; Kenneth B Margulies; Thomas P Cappola; David C Poole; Julio A Chirinos
Journal:  Circulation       Date:  2014-12-22       Impact factor: 29.690

Review 5.  Diastolic Stress Testing Along the Heart Failure Continuum.

Authors:  T Jake Samuel; Rhys Beaudry; Satyam Sarma; Vlad Zaha; Mark J Haykowsky; Michael D Nelson
Journal:  Curr Heart Fail Rep       Date:  2018-12

Review 6.  Heart failure with preserved ejection fraction and skeletal muscle physiology.

Authors:  Stephen D Farris; Farid Moussavi-Harami; April Stempien-Otero
Journal:  Heart Fail Rev       Date:  2017-03       Impact factor: 4.214

Review 7.  Advances in the pathophysiology and treatment of heart failure with preserved ejection fraction.

Authors:  Sara Tannenbaum; Gabriel T Sayer
Journal:  Curr Opin Cardiol       Date:  2015-05       Impact factor: 2.161

Review 8.  Heart failure with preserved ejection fraction: current understandings and challenges.

Authors:  Mads J Andersen; Barry A Borlaug
Journal:  Curr Cardiol Rep       Date:  2014-07       Impact factor: 2.931

9.  Evidence of microvascular dysfunction in heart failure with preserved ejection fraction.

Authors:  Joshua F Lee; Zachary Barrett-O'Keefe; Ryan S Garten; Ashley D Nelson; John J Ryan; Jose N Nativi; Russell S Richardson; D Walter Wray
Journal:  Heart       Date:  2015-11-13       Impact factor: 5.994

10.  Disruption of type 5 adenylyl cyclase prevents β-adrenergic receptor cardiomyopathy: a novel approach to β-adrenergic receptor blockade.

Authors:  Lin Yan; Stephen F Vatner; Dorothy E Vatner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-09-05       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.